Relevance of the metabotropic glutamate receptor (mGluR5) in the regulation of NREM-REM sleep cycle and homeostasis: Evidence from mGluR5 (-/-) mice

Behavioural Brain Research

Volumn 282, Issue , 2015, Pages 218-226

  Ahnaou, A ^a   Raeymaekers, L ^a   Steckler, T ^a   Drinkenbrug, W H I M ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Circadian; EEG; Homeostasis; MGluR5 ( ) mice; Slow wave activity; Stability of NREM REM sleep transitions

Indexed keywords

METABOTROPIC RECEPTOR 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DELTA RHYTHM; ELECTROENCEPHALOGRAM; GENOTYPE; HOMEOSTASIS; LOCOMOTION; MALE; MOUSE; NONHUMAN; NONREM SLEEP; PHENOTYPE; PROTEIN FUNCTION; REM SLEEP; SLEEP DEPRIVATION; SLEEP TIME; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; WAKEFULNESS; ANIMAL; C57BL MOUSE; DEFICIENCY; ELECTROENCEPHALOGRAPHY; KNOCKOUT MOUSE; PHYSIOLOGY; SLEEP STAGE;

ANIMALS; BODY TEMPERATURE; ELECTROENCEPHALOGRAPHY; HOMEOSTASIS; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, METABOTROPIC GLUTAMATE 5; SLEEP STAGES; SLEEP, REM;

EID: 84921628239     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.01.009     Document Type: Article

References (53)

1. Stenberg D. Neuroanatomy and neurochemistry of sleep. Cell Mol Life Sci 2007, 64:1187-1204.
2. Nakanishi S., Nakajima Y., Masu M., Ueda Y., Nakahara K., Watanabe D., et al. Glutamate receptors: brain function and signal transduction. Brain Res Rev 1998, 26:230-235.
3. Niswender C.M., Conn P.J. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 2010, 50:295-322.
4. Lea P.M., Custer S.J., Vicini S., Faden A.I. Neuronal and glial mGluR5 modulation prevents stretch-induced enhancement of NMDA receptor current. Pharmacol Biochem Behav 2002, 73:287-298.
5. Simonyi A., Schachtman T.R., Christoffersen G.R. The role of metabotropic glutamate receptor 5 in learning and memory processes. Drug News Persect 2005, 18:353-361.
6. Cleva R.M., Olive M.F. Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders. Molecules 2011, 16:2097-2106.
7. Hashimoto K., Malchow B., Falkai P., Schmitt A. Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci 2013, 263:367-377.
8. Herman E.J., Bubser M., Conn P.J., Jones C.K. Metabotropic glutamate receptors for new treatments in schizophrenia. Handb Exp Pharmacol 2012, 213:297-365.
9. Lea P.M., Faden A.I. Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders. Drug News Perspect 2003, 16:513-522.
10. Matosin N., Newell K.A. Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia. Neurosci Biobehav Rev 2013, 37:256-268.
11. Naylor E., Aillon D.V., Gabbert S., Harmon H., Johnson D.A., Wilson G.S., et al. Simultaneous real-time measurement of EEG/EMG and L-glutamate in mice: a biosensor study of neuronal activity during sleep. J Electroanal Chem 2011, 656:106-113.
12. Kodama T., Lai Y.Y., Siegel J.M. Enhanced glutamate release during REM sleep in the rostromedial medulla as measured by in vivo microdialysis. Brain Res 1998, 780:178-181.
13. Lopez-Rodriguez F., Medina-Ceja L., Wilson C.L., Jhung C.L., Morales-Villagram A. Changes in extracellular glutamate levels in rat orbitofrontal cortex during sleep and wakefulness. Arch Med Res 2007, 38:52-55.
14. Naido N., Ferber M., Galante R.J., McShane B., Hu J.H., Zimmerman J., et al. Role of Homer proteins in the maintenance of sleep-wake states. PLoS ONE 2012, 7:e35174.
15. Maret S., Dorsaz S., Gurcel L., Pradervand S., Petit B., Pfister C., et al. Homer1a is a core brain molecular correlate of sleep loss. Proc Natl Acad Sci U S A 2007, 104:20090-200905.
16. Ahnaou A, Langlois X, Steckler T, Bartolome-Nebreda JM, Drinkenburg WHIM. Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats. Psychopharmacology In press, //http://dx.doi.org/10.1007/s00213-014-3746-4.
17. Parmentier-Batteur S., O'Brien J.A., Doran S., Nguyen S.J., Flick R.B., Uslaner J.M., et al. Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration. Neuropharmacology 2012, 62:1453-1460.
18. Gilmour G., Broad L.M., Wafford K.A., Britton T., Colvin E.M., Fivush A., et al. In vitro characterization of the novel positive allosteric modulators of the mGlu5 receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat. Neuropharmacology 2013, 64:224-239.
19. Cavas M., Scesa G., Navarro J.F. Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2013, 40:18-25.
20. Paxinos G., Granklin K.B.J. The mouse brain in stereotaxic coordinates 2004, Elsevier/Academic Press, Amsterdam/Boston.
21. Naylor E., Harmon H., Gabbert S., Johnson D.A. Automated sleep deprivation: simulated gentle handling using a yoked control. Sleep 2010, 33(Suppl.):A108.
22. Lea P.M., Faden A.I. Metabotropic glutamate receptors subtype 5 antagonists MPEP and MTEP. CNS Drug Rev Summer 2006, 12:149-166.
23. Saper C.B., Scammell T.E., Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005, 437:1257-1263.
24. Alagarsamy S., Rouse S.T., Junge C., Hubert G.W., Gutman D., Smith Y., Conn P.J. NMDA-induced phosphorylation and regulation of mGluR5. Pharmacol Biochem Behav 2002, 73:299-306.
25. Heidbreder C.A., Bianchi M., Lacroix L.P., Faedo S., Perdona E., Remelli R., et al. Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo. Synapse 2003, 50:269-276.
26. Thomas L.S., Jane D.E., Gasparini F., Croucher M.J. Glutamate release inhibiting properties of the novel mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence. Neuropharmacology 2001, 41:523-527.
27. Armstrong-James M., Fox K. Evidence for a specific role for cortical NMDA receptors in slow-wave sleep. Brain Res 1988, 451:189-196.
28. Feinberg I., Campbell I.G. Ketamine administration during waking increases delta EEG intensity in rat sleep. Neuropsychopharmacology 1993, 9:41-48.
29. Smolders I., Clinckers R., Meurs A., De Bundel D., Portelli J., Ebinger G., et al. Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action. Neuropharmacology 2008, 54:1017-1028.
30. Stachowicz K., Gołembiowska K., Sowa M., Nowak G., Chojnacka-Wójcik E., Pilc A. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent. Neuropharmacology 2007, 53:741-748.
31. Ambrosini M.V., Giuditta A. Learning and sleep: the sequential hypothesis. Sleep Med Rev 2001, 5:477-490.
32. Maquet P. The role of sleep in learning and memory. Science 2001, 294:1048-1052.
33. McGaugh J.L. Memory-a century of consolidation. Science 2000, 287:248-251.
34. Lu Y.M., Jia Z., Janus C., Henderson J.T., Gerlai R., Wojtowicz J.M., et al. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci 1997, 17:5196-5205.
35. Jones B.E. Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral. Prog Brain Res 2004, 145:157-169.
36. Jones B.E. Paradoxical REM sleep promoting and permitting neuronal networks. Arch Ital Biol 2004, 142:379-396.
37. Maloney K.J., Cape E.G., Gotman J., Jones B.E. High-frequency gamma electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat. Neuroscience 1997, 76:541-555.
38. Jenkinson N., Kühn A.A., Brown P. Human γ-band activity and behavior. Exp Neurol 2013, 245:72-76.
39. Vyazovskiy V.V., Harris K.D. Sleep and the single neuron: the role of global slow oscillations in individual cell rest. Nat Rev Neurosci 2013, 14:443-451.
40. Staba R.J., Wilson C.L., Fried I., Engel J. Single neuron burst firing in the human hippocampus during sleep. Hippocampus 2002, 12:724-734.
41. Chiamulera C., Epping-Jordan M.P., Zocchi A., Marcon C., Cottiny C., Tacconi S., et al. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 2001, 4:873-874.
42. Gray L., van den Buuse M., Scarr E., Dean B., Hannan A.J. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation. Int J Neuropsychopharmacol 2009, 12:45-60.
43. Zhang C., Marek G.J. AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:62-71.
44. Molinaro G., Traficante A., Riozzi B., DiMenna L., Curto M., Pallottino S., et al. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice. Mol Pharmacol 2009, 76:379-387.
45. Halberstadt A.L., Lehmann-Masten V.D., Geyer M.A., Powell S.B. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacology 2011, 215:81-92.
46. Kinney G.G., Burno M., Campbell U.C., Hernandez L.M., Rodriguez D., Bristow L.J., et al. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J Pharmacol Exp Ther 2003, 306:116-123.
47. Borbély A.A. A two process model of sleep regulation. Hum Neurobiol 1982, 1:195-204.
48. Achermann P., Borbély A.A. Mathematical models of sleep regulation. Front Biosci 2003, 8:s683-s693.
49. Porkka-Heiskanen T., Strecker R.E., Thakkar M., Bjorkum A.A., Greene R.W., McCarley R.W. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997, 276:1265-1268.
50. Hefti K., Holst S.C., Sovago J., Bachmann V., Buck A., Ametamey S.M., et al. Increased metabotropic glutamate receptor subtype 5 availability in human brain after one night without sleep. Biol Psychiatry 2013, 73:161-168.
51. Tononi G., Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev 2006, 10:49-62.
52. Tononi G., Cirelli C. Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration. Neuron 2014, 81:12-34.
53. Jew C.P., Wu C.S., Sun H., Zhu J., Huang J.Y., Yu D., et al. mGluR5 ablation in cortical glutamatergic neurons increases novelty-induced locomotion. PLoS ONE 2013, 5(8):e70415.